BrightSpec
PrivateLast Round
Series C
Dec 14, 2022
Total Funding Raised
$22.7M
Company Overview
BrightSpec is a life science tools company that commercializes instruments using molecular rotational resonance (MRR) spectroscopy for the structural identification and quantitation of small molecules.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Drug Discovery, Smart Manufacturing, Quality Management
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BrightSpec Comparables
Compare BrightSpec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Magritek | 80% | |
| Q Magnetics | 77% | |
| Thermo Fisher Scientific Inc. | 74% |
BrightSpec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 14, 2022 | ||||
| Series B | Mar 1, 2019 | ||||
| Grant | May 1, 2018 | ||||
| Grant | May 1, 2018 | ||||
| Grant | Aug 1, 2015 |
Key People
Founding team and executive leadership
BrightSpec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Virginia LVG Seed Fund | Series B, Series C |
| Arboretum Ventures | Series C |
| NIH RADx | Grant |
| Genoa Ventures | Series C |
| Felton Group | Series C |
| Virginia Catalyst | Grant |
| Medvest Capital | Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 28, 2025
Added Kusak Cut Glass Works, a startup in glass manufacturing.
- Oct 28, 2025
Received a 2025 R&D 100 Award for its spectraMRR platform.
BrightSpec Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BrightSpec's valuation, stock price, and market status.
Is BrightSpec a public or private company?
BrightSpec is a private company.
What is the current stock price of BrightSpec?
BrightSpec is a private company, so its shares have no public market price. Caplight tracks BrightSpec's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BrightSpec worth (valuation)?
Valuation information for BrightSpec is not publicly available.
Can I buy BrightSpec stock?
BrightSpec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BrightSpec's last funding round?
BrightSpec's most recent funding round was Series C on December 14, 2022.
Who are the main investors in BrightSpec?
Key investors in BrightSpec include Arboretum Ventures, NIH RADx, Genoa Ventures, Virginia Catalyst, National Science Foundation.
Will BrightSpec IPO soon?
No public IPO plans have been announced for BrightSpec.
How can I track BrightSpec secondary market activity?
Caplight tracks bids, offers, and trades in BrightSpec's shares on secondary markets.